Anika Therapeutics Inc
ANIK
ANIK: Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
moreShow ANIK Financials
Recent trades of ANIK by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ANIK's directors and management
Government lobbying spending instances
-
$10,000 Oct 21, 2016 Issue: Health Issues
New patents grants
-
Patent Title: Methods and compositions for treating tendon degeneration Oct. 15, 2019
-
Patent Title: Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid Dec. 04, 2012
-
Patent Title: Crosslinked hyaluronic acid compositions for tissue augmentation Feb. 28, 2012
Federal grants, loans, and purchases
Followers on ANIK's company Twitter account
Number of mentions of ANIK in WallStreetBets Daily Discussion
Recent insights relating to ANIK
Recent picks made for ANIK stock on CNBC
ETFs with the largest estimated holdings in ANIK
Flights by private jets registered to ANIK